Risk of progression of Barrett's esophagus in patients with cirrhosis

被引:3
|
作者
Apfel, Tehilla [1 ]
Lopez, Rocio [1 ]
Sanaka, Madhusudhan R. [1 ]
Thota, Prashanthi N. [1 ]
机构
[1] Cleveland Clin Fdn, Dept Gen Internal Med, Cleveland, OH 44195 USA
关键词
Liver cirrhosis; Barrett's esophagus; Dysplasia; Esophageal neoplasm; Progression; NONALCOHOLIC FATTY LIVER; HIGH-GRADE DYSPLASIA; GASTROESOPHAGEAL-REFLUX; METABOLIC SYNDROME; ADENOCARCINOMA; VARICES; METAANALYSIS; ADIPOKINES; DISEASE;
D O I
10.3748/wjg.v23.i18.3287
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM To study Barrett's esophagus (BE) in cirrhosis and assess progression to esophageal adenocarcinoma (EAC) compared to non-cirrhotic BE controls. METHODS Cirrhotic patients who were found to have endoscopic evidence of BE confirmed by the presence of intestinal metaplasia on histology from 1/1/2000 to 12/1/2015 at Cleveland Clinic were included. Cirrhotic patients were matched 1: 4 to BE controls without cirrhosis. Age, gender, race, BE length, hiatal hernia size, Child-Pugh (CP) class and histological findings were recorded. Cases and controls without high-grade dysplasia (HGD)/EAC and who had follow-up endoscopies were studied for incidence of dysplasia/EAC and to assess progression rates. Univariable conditional logistic regression was done to assess differences in baseline characteristics between the two groups. RESULTS A total of 57 patients with cirrhosis and BE were matched with 228 controls (BE without cirrhosis). The prevalence of dysplasia in cirrhosis and controls were similar with 8.8% vs 12% with low grade dysplasia (LGD) and 12.3 % vs 19.7% with HGD or EAC (P = 0.1). In the incidence cohort of 44 patients with median follow-up time of 2.7 years [interquartile range 1.0, 4.8], there were 7 cases of LGD, 2 cases of HGD, and 2 cases of EAC. There were no differences in incidence rates of HGD/ EAC in nondysplastic BE between cirrhotic cases and noncirrhotic controls (1.4 vs 1.1 per 100 person-years, P = 0.8). In LGD, cirrhotic patients were found to have higher rates of progression to HGD/EAC compared to control group though this did not reach statistical significance (13.7 vs 8.1 per 100 person-years, P = 0.51). A significant association was found between a higher CP class and neoplastic progression of BE in cirrhotic patients (HR = 7.9, 95% CI: 2.0-30.9, P = 0.003). CONCLUSION Cirrhotics with worsening liver function are at increased risk of progression of BE. More frequent endoscopic surveillance might be warranted in such patients.
引用
收藏
页码:3287 / 3294
页数:8
相关论文
共 50 条
  • [21] Risk factors for neoplastic progression in Barrett's esophagus
    Wiseman, Elizabeth F.
    Ang, Yeng S.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (32) : 3672 - 3683
  • [22] Secular Trends in Patients Diagnosed with Barrett's Esophagus
    Yachimski, Patrick
    Lee, Rebecca A.
    Tramontano, Angela
    Nishioka, Norman S.
    Hur, Chin
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (04) : 960 - 966
  • [23] Surveillance of patients with Barrett's esophagus
    Endlicher, E
    Knüchel, R
    Messmann, H
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2001, 39 (08): : 593 - 600
  • [24] Neutrophil to lymphocyte ratio and risk of neoplastic progression in patients with Barrett's esophagus
    Peleg, Noam
    Schmilovitz-Weiss, Hemda
    Shamah, Steven
    Schwartz, Ariel
    Dotan, Iris
    Sapoznikov, Boris
    ENDOSCOPY, 2021, 53 (08) : 774 - 781
  • [25] Improving Dysplasia Detection in Barrett's Esophagus
    Holzwanger, Erik A.
    Liu, Alex Y.
    Iyer, Prasad G.
    TECHNIQUES AND INNOVATIONS IN GASTROINTESTINAL ENDOSCOPY, 2023, 25 (02): : 157 - 166
  • [26] Hiatal hernia and the risk of Barrett's esophagus
    Andrici, Juliana
    Tio, Martin
    Cox, Michael R.
    Eslick, Guy D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (03) : 415 - 431
  • [27] Early events during neoplastic progression in Barrett's esophagus
    Reid, Brian J.
    CANCER BIOMARKERS, 2011, 9 (1-6) : 307 - 324
  • [28] How to diagnose and manage patients with Barrett's esophagus in China
    Huang, Qin
    Fang, Dian Chun
    Fang, Jing Yuan
    Chen, Min Hu
    Zhang, Jun
    Lin, Lin
    Dai, Ning
    Yu, Cheng Gong
    Zhang, Hong Jie
    JOURNAL OF DIGESTIVE DISEASES, 2012, 13 (03) : 123 - 132
  • [29] Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia
    Parasa, Sravanthi
    Vennalaganti, Sreekar
    Gaddam, Srinivas
    Vennalaganti, Prashanth
    Young, Patrick
    Gupta, Neil
    Thota, Prashanthi
    Cash, Brooks
    Mathur, Sharad
    Sampliner, Richard
    Moawad, Fouad
    Lieberman, David
    Bansal, Ajay
    Kennedy, Kevin F.
    Vargo, John
    Falk, Gary
    Spaander, Manon
    Bruno, Marco
    Sharma, Prateek
    GASTROENTEROLOGY, 2018, 154 (05) : 1282 - +
  • [30] Benefit of baseline cytometry for surveillance of patients with Barrett's esophagus
    Vogt, Nicole
    Schoenegg, Ren
    Gschossmann, Juergen M.
    Borovicka, Jan
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2010, 24 (05): : 1144 - 1150